Cellectis SA (CLLS)

3.09 -0.03 (-0.96%) USD  |  NASDAQ  |  Sep 11, 16:00
3.09 0.00 (0.00%) After-Hours: 16:43
More

Cellectis Gross Profit (TTM) : 37.38M for June 30, 2026

Gross Profit (TTM) Chart

View Gross Profit (TTM) for CLLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit (TTM) Chart
Start Trial

Historical Gross Profit (TTM) Data

View and export this data back to 2015. Start Trial.
Date Value
June 30, 2026 37.38M
March 31, 2026 48.43M
December 31, 2025 52.91M
September 30, 2025 54.46M
June 30, 2025 35.91M
March 31, 2025 27.38M
December 31, 2024 21.61M
September 30, 2024 9.712M
June 30, 2024 -6.243M
March 31, 2024 -13.81M
December 31, 2023 -18.42M
September 30, 2023 1.972M
June 30, 2023 1.974M
March 31, 2023 2.715M
December 31, 2022 3.755M
September 30, 2022 -4.976M
June 30, 2022 -1.404M
March 31, 2022 1.513M
December 31, 2021 22.58M
September 30, 2021 11.77M
June 30, 2021 11.03M
March 31, 2021 8.684M
December 31, 2020 36.76M
Date Value
September 30, 2020 39.73M
June 30, 2020 45.60M
March 31, 2020 47.24M
December 31, 2019 1.141M
September 30, 2019 2.618M
June 30, 2019 -1.575M
March 31, 2019 3.892M
December 31, 2018 9.606M
September 30, 2018 13.50M
June 30, 2018 18.95M
March 31, 2018 20.38M
December 31, 2017 21.43M
September 30, 2017 24.57M
June 30, 2017 30.88M
March 31, 2017 42.56M
December 31, 2016 43.32M
September 30, 2016 64.13M
June 30, 2016 60.41M
March 31, 2016 50.80M
December 31, 2015 52.84M
September 30, 2015 24.74M
June 30, 2015 16.67M
March 31, 2015 8.994M

Gross Profit Definition

Annual, Interim and Preliminary Items - Commercial, Other Financial Companies

Read full definition.

Gross Profit (TTM) Range, Past 5 Years

View Gross Profit (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit (TTM) Benchmarks

View Gross Profit (TTM) Benchmarks
Start Trial
DBV Technologies SA -12.78M
Akari Therapeutics Plc 0.00
EDAP TMS SA 30.21M
Autolus Therapeutics Plc 15.09M
Evaxion AS 0.00